0001334971-17-000002.txt : 20171017 0001334971-17-000002.hdr.sgml : 20171017 20171017171322 ACCESSION NUMBER: 0001334971-17-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20171017 DATE AS OF CHANGE: 20171017 EFFECTIVENESS DATE: 20171017 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CYTIMMUNE SCIENCES INC CENTRAL INDEX KEY: 0001334971 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-296902 FILM NUMBER: 171141236 BUSINESS ADDRESS: STREET 1: 15010 BROSCHART ROAD CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 301-825-3041 MAIL ADDRESS: STREET 1: 15010 BROSCHART ROAD CITY: ROCKVILLE STATE: MD ZIP: 20850 D 1 primary_doc.xml X0708 D LIVE 0001334971 CYTIMMUNE SCIENCES INC 15010 BROSCHART ROAD ROCKVILLE MD MARYLAND 20850 301-825-3041 DELAWARE None None Corporation true Lawrence Tamarkin 15010 Broschart Road Rockville MD MARYLAND 20850 Executive Officer Director John W. Holaday 15010 Broschart Road Rockville MD MARYLAND 20850 Director Neal Cohen 15010 Broschart Road Rockville MD MARYLAND 20850 Director Marc Stanley 15010 Broschart Road Rockville MD MARYLAND 20850 Director Ira Shapiro 15010 Broschart Road Rockville MD MARYLAND 20850 Director Hidetaka Kentaro Itani 15010 Broschart Road Rockville MD MARYLAND 20850 Director Mitchell S. Marder 15010 Broschart Road Rockville MD MARYLAND 20850 Executive Officer Gary Rosenfeld 15010 Broschart Road Rockville MD MARYLAND 20850 Executive Officer Biotechnology Decline to Disclose 06b false 2017-10-02 false true true Convertible promissory note and shares of common stock issuable upon conversion. false 0 2000000 30000 1970000 false 2 0 0 0 false CYTIMMUNE SCIENCES INC /s/ Mitchell S. Marder Mitchell S. Marder Executive VP, Corporate Development & Chief Legal Officer 2017-10-13